Medication-Related Oral Side Effects: Recognition in Practice

The prescription pad is one of the most common sources of the oral complaint that the patient brings to the dental office, and the clinician who does not think of the medication may spend the appointment treating the symptom that the drug created. The list of the agents that affect the mouth grow...

The prescription pad is one of the most common sources of the oral complaint that the patient brings to the dental office, and the clinician who does not think of the medication may spend the appointment treating the symptom that the drug created. The list of the agents that affect the mouth grows every year, and the reactions range from the dry mouth that follows the antidepressant to the gingival overgrowth that the calcium channel blocker produces and the osteonecrosis that the antiresorptive agent carries. The recognition begins with the medication history that the clinician takes at every visit, and the management begins with the conversation that the physician joins. This article reviews the presentations that the clinician should recognize and the practical management that follows.

The Mouth as the Mirror of the Medication

The oral mucosa is a fast-turnover tissue with a rich blood supply, which makes it the surface that often reflects the systemic drug before the patient reports the effect anywhere else. The dry mouth, the altered taste, the ulcer, and the pigmentation each may be the first sign of the medication that the patient takes for a condition the dental team has never discussed. The clinician who reviews the medication list at the recall examination catches the reaction at the stage when the intervention is simple.

The Common Presentations

The reactions that the clinician meets most often are grouped by the drug class that produces them, and the pattern of the presentation points to the agent even before the prescription is confirmed.

The timing is the detail that the clinician should record, because the reaction that begins after the prescription and fades after the withdrawal is the reaction of the drug. The patient may not connect the mouth ulcer with the tablet started two weeks earlier, and the question that the clinician asks at the review is often the one that the history answers.

Xerostomia and the Caries Risk

The reduced salivary flow is the most frequent oral effect of the medication, and the clinician should treat it as the risk factor for the caries and the erosion rather than as the minor inconvenience. The saliva that bathes the tooth carries the buffer, the antimicrobial protein, and the calcium that the enamel needs, and the mouth that loses the flow loses the protection with it. The patient on the multiple agents, particularly the combination of the antidepressant and the antihypertensive, is the patient whose mouth dries the most.

The management begins with the review of the medication with the prescriber, because the substitution of the agent that spares the saliva is the most effective step where the clinical situation allows it. The patient is then taught the measures that stimulate the flow and the substitutes that moisten the mouth, and the fluoride that the dry mouth demands is prescribed at the concentration that the caries risk justifies.

Gingival Overgrowth and the Mucosal Reactions

The gingival overgrowth that the calcium channel blocker and the anticonvulsant produce begins at the interdental papilla and spreads across the attached gingiva, and the plaque control determines how far the enlargement progresses. The patient who maintains the meticulous hygiene often keeps the overgrowth at the level that needs no surgery, while the patient with the heavy plaque develops the enlargement that interferes with the function and the esthetics. The discontinuation of the drug with the physician and the meticulous debridement are the steps that reverse the process in the early case.

The mucosal ulcer, the lichenoid reaction, and the pigmentation are the other presentations that the clinician should attribute to the medication when the pattern fits. The lichenoid reaction that the antihypertensive and the antidiabetic agent produce resembles the oral lichen planus, and the history of the recent prescription is the clue that separates the drug reaction from the idiopathic disease.

The older patient carries the special risk, because the medication list grows with the years and the salivary gland loses the reserve with the age. The patient who takes the diuretic, the antihypertensive, and the antidepressant together presents the mouth that is dry beyond the sum of the single effects, and the clinician should plan the recall interval and the fluoride program for that patient rather than for the average.

The Management in Practice

The dry mouth is the condition in which the daily care makes the measurable difference, and the patient who keeps the routine protects the dentition that the reduced saliva leaves exposed. A soft electric brush such as the BrushO cleans the vulnerable cervical area with the gentle and the controlled movement, and the fluoride toothpaste that follows coats the root surface that the dry mouth leaves at risk.

Clinical Key Points

- Take the full medication history at every recall examination.

- Treat the dry mouth as a caries risk rather than a nuisance.

- Review the prescription with the physician before changing the plan.

- Control the plaque to limit the gingival overgrowth.

- Attribute the mucosal lesion to the drug when the pattern and the timing fit.

Conclusion

The mouth tells the story of the medication that the patient takes, and the clinician who reads the signs gives the patient the care that the systemic therapy demands. The dry mouth, the overgrowth, and the mucosal reaction each respond to the recognition that comes before the damage, and the bridge between the dental team and the physician is the prescription list that the clinician reviews with the care it deserves.